Volume 14, Issue 11, Pages (November 2007)

Slides:



Advertisements
Similar presentations
Structure-Based Engineering of Angucyclinone 6-Ketoreductases
Advertisements

Volume 17, Issue 1, Pages (January 2010)
Structural Basis for the Highly Selective Inhibition of MMP-13
Ross Alexander Robinson, Xin Lu, Edith Yvonne Jones, Christian Siebold 
Kristopher Josephson, Naomi J. Logsdon, Mark R. Walter  Immunity 
Structure of an LDLR-RAP Complex Reveals a General Mode for Ligand Recognition by Lipoprotein Receptors  Carl Fisher, Natalia Beglova, Stephen C. Blacklow 
Volume 17, Issue 11, Pages (November 2009)
Volume 21, Issue 5, Pages (May 2013)
Volume 21, Issue 2, Pages (February 2014)
Volume 12, Issue 2, Pages (February 2005)
Volume 25, Issue 8, Pages (August 2017)
AG-221 structure and binding characteristics.
Volume 124, Issue 2, Pages (January 2006)
Volume 19, Issue 10, Pages (October 2012)
Allosteric Effects of the Oncogenic RasQ61L Mutant on Raf-RBD
Volume 10, Issue 12, Pages (December 2002)
Volume 18, Issue 11, Pages (November 2011)
Volume 19, Issue 1, Pages (January 2011)
Volume 14, Issue 5, Pages (May 2007)
Volume 12, Issue 1, Pages (January 2005)
Volume 20, Issue 5, Pages (May 2012)
Volume 20, Issue 2, Pages (February 2012)
Volume 7, Issue 2, Pages (February 1999)
Rong Shi, Laura McDonald, Miroslaw Cygler, Irena Ekiel  Structure 
Volume 20, Issue 6, Pages (December 2005)
Solution and Crystal Structures of a Sugar Binding Site Mutant of Cyanovirin-N: No Evidence of Domain Swapping  Elena Matei, William Furey, Angela M.
Volume 21, Issue 5, Pages (May 2014)
Ins and Outs of Kinase DFG Motifs
Ross Alexander Robinson, Xin Lu, Edith Yvonne Jones, Christian Siebold 
Volume 17, Issue 3, Pages (March 2009)
Volume 14, Issue 11, Pages (November 2007)
Structural Analysis of Ligand Stimulation of the Histidine Kinase NarX
Sachin Surade, Tom L. Blundell  Chemistry & Biology 
Volume 14, Issue 5, Pages (May 2006)
Volume 12, Issue 11, Pages (November 2005)
Volume 21, Issue 2, Pages (February 2014)
Volume 19, Issue 9, Pages (September 2011)
Volume 7, Issue 4, Pages (April 2005)
Volume 16, Issue 5, Pages (May 2009)
A Drug-Drug Interaction Crystallizes a New Entry Point into the UPR
Volume 15, Issue 3, Pages (March 2008)
Structural Basis for the Highly Selective Inhibition of MMP-13
Structural and Biophysical Studies of the Human IL-7/IL-7Rα Complex
Volume 22, Issue 2, Pages (February 2014)
Volume 17, Issue 10, Pages (October 2009)
Structure-Based Engineering of Angucyclinone 6-Ketoreductases
Structural Insights into the pH-Dependent Conformational Change and Collagen Recognition of the Human Mannose Receptor  Zhenzheng Hu, Xiangyi Shi, Bowen.
Crystal Structures of Mycobacterium tuberculosis KasA Show Mode of Action within Cell Wall Biosynthesis and its Inhibition by Thiolactomycin  Sylvia R.
Volume 18, Issue 9, Pages (September 2010)
Crystal Structures of Mycobacterium tuberculosis KasA Show Mode of Action within Cell Wall Biosynthesis and its Inhibition by Thiolactomycin  Sylvia R.
Conformation-Selective ATP-Competitive Inhibitors Control Regulatory Interactions and Noncatalytic Functions of Mitogen-Activated Protein Kinases  Sanjay B.
Volume 24, Issue 9, Pages (September 2016)
DNA Synthesis across an Abasic Lesion by Human DNA Polymerase ι
Structure of the Staphylococcus aureus AgrA LytTR Domain Bound to DNA Reveals a Beta Fold with an Unusual Mode of Binding  David J. Sidote, Christopher.
Volume 23, Issue 12, Pages (December 2015)
Structural Basis of Swinholide A Binding to Actin
Alec E. Hodel, Paul D. Gershon, Florante A. Quiocho  Molecular Cell 
Ramon Hurtado-Guerrero, Daan M.F. van Aalten  Chemistry & Biology 
Volume 21, Issue 10, Pages (October 2014)
Molecular Similarity Analysis Uncovers Heterogeneous Structure-Activity Relationships and Variable Activity Landscapes  Lisa Peltason, Jürgen Bajorath 
The Structure of JNK3 in Complex with Small Molecule Inhibitors
Volume 20, Issue 1, Pages (January 2012)
Kristopher Josephson, Naomi J. Logsdon, Mark R. Walter  Immunity 
Volume 20, Issue 7, Pages (July 2012)
Volume 19, Issue 2, Pages (February 2012)
Structure-Based Engineering of Angucyclinone 6-Ketoreductases
Volume 7, Issue 2, Pages (February 1999)
Structure of the Mtb CarD/RNAP β-Lobes Complex Reveals the Molecular Basis of Interaction and Presents a Distinct DNA-Binding Domain for Mtb CarD  Gulcin.
Volume 21, Issue 6, Pages (June 2013)
Volume 20, Issue 5, Pages (May 2012)
Presentation transcript:

Volume 14, Issue 11, Pages 1294-1303 (November 2007) Structural Proof of a Dimeric Positive Modulator Bridging Two Identical AMPA Receptor- Binding Sites  Birgitte H. Kaae, Kasper Harpsøe, Jette S. Kastrup, Alberto Contreras Sanz, Darryl S. Pickering, Bjørn Metzler, Rasmus P. Clausen, Michael Gajhede, Per Sauerberg, Tommy Liljefors, Ulf Madsen  Chemistry & Biology  Volume 14, Issue 11, Pages 1294-1303 (November 2007) DOI: 10.1016/j.chembiol.2007.10.012 Copyright © 2007 Elsevier Ltd Terms and Conditions

Figure 1 Known Modulators of AMPA Receptors as Well as Designed Monomeric 1a,b and Dimeric Compounds 2a,b R1 is either a methyl group or an isopropyl group. R2 can be various substituents, as reported by Ornstein et al. [17]. Chemistry & Biology 2007 14, 1294-1303DOI: (10.1016/j.chembiol.2007.10.012) Copyright © 2007 Elsevier Ltd Terms and Conditions

Figure 2 The Design of Dimeric Compounds (A) Binding mode of CTZ (gray carbons) and aniracetam (green carbons: two overlapping orientations are present in the structure, each with an occupancy of 0.5) in the symmetrical dimer interface of the ligand-binding core of GluR2. (B) Predicted binding mode of (R,R)-2a (cyan carbons) superimposed on the binding mode of CTZ (gray carbons). Compound 2b was designed on the basis of results obtained with analogs of known biarylpropylsulfonamides (Figure 1) described by Ornstein et al. [17]. Chemistry & Biology 2007 14, 1294-1303DOI: (10.1016/j.chembiol.2007.10.012) Copyright © 2007 Elsevier Ltd Terms and Conditions

Figure 3 Synthesis of Compounds (i) LiHMDS, THF, −78°C; (ii) BH3•S(CH3)2, THF, reflux; (iii) RSO2Cl, TEA, CH2Cl2, 0°C ; (iv) H5IO6, I2, conc. H2SO4, AcOH, H2O, 60°C; (v) Aryl halide, Aryl boronic ester, PdCl2(PPh3)2, PPh3, K2CO3, H2O, 1.4-dioxane, 80°C; (vi) 1g, LiCl, Pd(OAc)2, In, DMF, 100°C; (vii) chiral HPLC. Chemistry & Biology 2007 14, 1294-1303DOI: (10.1016/j.chembiol.2007.10.012) Copyright © 2007 Elsevier Ltd Terms and Conditions

Figure 4 Pharmacology of (R,R)-2a Subtype selectivity profile of (R,R)-2a. Shown are mean ± SEM responses of data pooled from all experiments by normalizing the measured potentiation to the calculated maximal potentiation for each oocyte. GluR2(Q)i (open circles, dashed line); GluR2(Q)o (closed circles, dotted line). Inset: traces from one GluR2(Q)i experiment. See Table 2 for EC50 values. Chemistry & Biology 2007 14, 1294-1303DOI: (10.1016/j.chembiol.2007.10.012) Copyright © 2007 Elsevier Ltd Terms and Conditions

Figure 5 Bridging of Two Allosteric Binding Sites within the Ligand-Binding Core of GluR2 by (R,R)-2a (A) The dimeric structure of GluR2-S1S2J-N775S in complex with (S)-Glu and (R,R)-2a. A ribbon representation of the two protomers comprising the dimer is shown in cyan (molecule A) and green (molecule B). Accordingly, a transparent surface representation of residues in the vicinity (max. 4 Å) of (R,R)-2a is shown. (R,R)-2a (magenta) and (S)-Glu (yellow) are displayed in stick representation. Two water molecules mediating interactions between (R,R)-2a and protein are shown as red spheres. (B) Close-up view of one half of the symmetric (R,R)-2a molecule located in the binding site (shown in magenta stick representation). The view is different from that in Figure 4A). A transparent surface representation of the amino acid residues interacting with (R,R)-2a is shown (molecule A: cyan; molecule B: green). All amino acid residues within 4 Å of (R,R)-2a are shown. The atoms have been colored according to type. The interacting water molecule is shown as a red sphere. Hydrogen bonds from (R,R)-2a are displayed as stippled lines (max. 3.5 Å). (C) Close-up view of the CTZ-binding mode in GluR2-S1S2J-N775S (PDB code: 1LBC). The view is similar to that in Figure 4B). CTZ is shown in magenta stick representation. A transparent surface representation of the residues interacting with CTZ is shown (molecule A: cyan; molecule C: green). All amino acid residues within 4 Å of CTZ are shown. The atoms have been colored according to type. The interacting water molecules are shown as red spheres. Chemistry & Biology 2007 14, 1294-1303DOI: (10.1016/j.chembiol.2007.10.012) Copyright © 2007 Elsevier Ltd Terms and Conditions